Improving antibiotic prescribing for UTIs

UTIs

Major new research study to improve antibiotic prescribing for urinary tract infections (UTIs) in primary care New research led by the University of Bristol aims to help GPs choose the best antibiotic for treating UTIs and reducing antimicrobial resistance (AMR), thanks to a £3 million award by the National Institute for Health and Care Research […]

Read More… from Improving antibiotic prescribing for UTIs

Testing strategy for chronic liver disease

liver

Testing strategy for chronic liver disease: A research team from the Department of Medicine III at MedUni Vienna and University Hospital Vienna has conducted a large-scale study showing the important value of repeated liver assessments by a novel method that can significantly improve risk assessment in patients with chronic liver disease. The dynamics of regular […]

Read More… from Testing strategy for chronic liver disease

MS: new biomarker discovered

new biomarker

MS: new biomarker discovered: A study conducted by researchers from the Department of Neurology at MedUni Vienna and University Hospital Vienna has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye. Use of the procedure, which is already […]

Read More… from MS: new biomarker discovered

Peritoneal dialysis: New treatment option against infections

Peritoneal dialysis

Peritoneal dialysis: New treatment option against infections: Inflammations of the peritoneum (peritonitis) are as frequent as they are feared complications in peritoneal dialysis, a form of kidney replacement therapy for independent use at home. The bacteria responsible for the life-threatening infections are becoming increasingly resistant to many antibiotics. A research team led by Markus Zeitlinger, […]

Read More… from Peritoneal dialysis: New treatment option against infections

Targeting disease control beyond under 5s

disease control

Targeting disease control beyond under 5s: Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study. The research, led by Murdoch Children’s Research Institute and the Institute for Health Metrics and Evaluation, has found […]

Read More… from Targeting disease control beyond under 5s

Parasites: Potent new compound discovery has breakthrough potential for certain diseases

parasites

Scientists have discovered a new class of compound that is potentially active against trypanosome parasites that cause human African trypanosomiasis (or sleeping sickness) and Chagas disease. The ground-breaking findings – published in the journal Science and led by researchers at the University of Glasgow and Novartis Global Health (formerly Novartis Institutes for Tropical Diseases) – […]

Read More… from Parasites: Potent new compound discovery has breakthrough potential for certain diseases

Cholesterol passport for adolescents

cholesterol

The United Nations Declaration of Human Rights that everyone has the right to life could as well be extended to include the right to an “elevated cholesterol-free life”, a viewpoint by Dr Andrew Agbaje of the University of Eastern Finland, published in Frontiers in Pediatrics, concludes. Globally, atherosclerotic cardiovascular disease has remained the leading cause […]

Read More… from Cholesterol passport for adolescents

Key gene that blocks the ‘spillover’ of avian flu to humans discovered

avian

Understanding the genetic make-up of currently circulating avian flu strains may offer one of the best lines of defence against widespread human transmission. This is according to new research which has found a key human gene responsible for blocking most avian flu viruses from spilling over into people. The latest international study into the pandemic […]

Read More… from Key gene that blocks the ‘spillover’ of avian flu to humans discovered

Anthony Nolan award winners at prestigious ceremony

karolinska

Researchers win prestigious awards for dedication to lifesaving research in support of Anthony Nolan: Dr Robert Wynn, Consultant Paediatric Haematologist at the Manchester Children’s Hospital, has won Clinical Supporter of the Year at the Anthony Nolan Supporter Awards (ANSAs) 2023 for his exceptional work championing cord blood research. While Hatem Nawar, Cloud Customer Engineer for […]

Read More… from Anthony Nolan award winners at prestigious ceremony

Beta-2 agonists not associated with a lower risk of Parkinson’s

beta-2 agonists

Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been associated with a reduced risk of Parkinson’s disease in some previous epidemiological studies, this association was not found in a recent register-based study from the University of Eastern Finland. The findings were published […]

Read More… from Beta-2 agonists not associated with a lower risk of Parkinson’s